Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
Clin Exp Dermatol ; 34(5): 582-6, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19094132

RESUMEN

BACKGROUND: Psoriasis is an immune cell-mediated disease in which cytokines play an important role. Studies have been performed to explore the relationship between the disease and cytokine blood levels with a view to finding a biomarker for monitoring disease severity/activity and treatment efficacy. AIM: To investigate the levels of transforming growth factor-beta1 (TGF-beta1) in patients with mild psoriasis vulgaris (PV) and the possible use of this cytokine in monitoring treatment with biological drugs. METHODS: Serum levels of TGF-beta1 were estimated in 33 untreated patients (PI group), in 7 of these patients (PII group) before and after 3 months of treatment with one of two biological drugs (etanercept and efalizumab) and in 19 healthy volunteers (control group). RESULTS: Significantly (P < 0.0001) higher serum levels of TGF-beta1 were found in the PI group [Psoriasis Area and Severity Index (PASI) 9-10] compared with the 19 healthy volunteers. In the PII group, after the administration of one of the biological drugs, a 50% reduction in PASI and a significant (P = 0.032) decrease in TGF-beta1 was noted. CONCLUSIONS: Raised TGF-beta1 levels in patients with mild PV decreased in tandem with a decrease in PASI after biological drug treatment. Hence, TGF-beta1 levels seem to be sensitive to changes in disease severity.


Asunto(s)
Inmunosupresores/uso terapéutico , Psoriasis/sangre , Psoriasis/tratamiento farmacológico , Factor de Crecimiento Transformador beta1/sangre , Adulto , Anciano , Anticuerpos Monoclonales/uso terapéutico , Anticuerpos Monoclonales Humanizados , Biomarcadores/sangre , Etanercept , Femenino , Humanos , Inmunoglobulina G/uso terapéutico , Masculino , Persona de Mediana Edad , Receptores del Factor de Necrosis Tumoral/uso terapéutico , Índice de Severidad de la Enfermedad , Resultado del Tratamiento , Adulto Joven
4.
Diabetes Res Clin Pract ; 49(2-3): 113-8, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10963822

RESUMEN

Ca(2+)-Mg(2+)-ATPase is an important regulator of intracellular calcium concentration and therefore, of erythrocyte deformability. We have investigated the possible relationship between Ca(2+)-Mg(2+)-ATPase activity (ATPase) and ionized calcium (Ca(2+)), in diabetic patients with peripheral neuropathy. A total of 104 Type 2 diabetic patients (57 neuropathic and 47 non-neuropathic) and 25 non-diabetic subjects were studied. After an overnight fast, blood was taken for Ca(2+)-Mg(2+)-ATPase activity, Ca(2+), Mg(2+), PTH and HbA(1c). The neuropathy study group had significantly lower levels of ATPase, 6.6 (95% CI, 5.6-7.7) nmol/mg/min compared to controls 7. 1 (6.2-8.3) nmol/mg/min, P<0.001 and to diabetic patients without neuropathy 7.0 (6.0-8.1) nmol/mg/min, P<0.001. The study group had also lower levels of Ca(2+) (0.89+/-0.18 mmol/l vs. control 1.08+/-0. 24 mmol/l, P<0.01 and non-neuropathic 0.98+/-0.27 mmol/l, P<0.05) and Mg(2+) (0.73+/-0.13 mmol/l vs. control 0.81+/-0.14 mmol/l, P<0. 05), despite similar PTH levels. In diabetic subjects, no correlation was found between ATPase or Ca(2+) with glucose, HbA(1c), age or duration of diabetes. We conclude that in patients with diabetic neuropathy there are abnormalities of Ca(2+)-Mg(2+)-ATPase activity and Ca(2+). This provides further support for the role of microangiopathy in the pathogenesis of neuropathy.


Asunto(s)
ATPasa de Ca(2+) y Mg(2+)/sangre , Calcio/sangre , Diabetes Mellitus Tipo 2/sangre , Neuropatías Diabéticas/sangre , Glucemia/metabolismo , Diabetes Mellitus Tipo 2/enzimología , Neuropatías Diabéticas/clasificación , Neuropatías Diabéticas/fisiopatología , Femenino , Hemoglobina Glucada/análisis , Humanos , Magnesio/sangre , Masculino , Persona de Mediana Edad , Hormona Paratiroidea/sangre , Valores de Referencia
5.
Contact Dermatitis ; 42(2): 85-9, 2000 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10703630

RESUMEN

Quercetin is a bioflavonoid with antioxidant and anti-inflammatory activity. The purpose of this study was to examine the effect of quercetin on acute skin irritation, with special interest in the skin barrier function recovery. Acute irritant contact dermatitis was induced in 15 patients by 24-h occlusion of 2% sodium lauryl sulfate (SLS) (day (D) 1). The influence of application on SLS-irritated skin of topical quercetin for 5 consecutive Ds, compared to vehicle and controls, was studied. Parameters measured were transepidermal water loss (TEWL) and erythema index. Final measurements were taken on D 7 after a 1-D rest period. TEWL and the erythema index continued to rise 2 D after application of SLS and 1 D after treatment with quercetin, vehicle or controls. Both TEWL and erythema values at D 7 did not return to values before the SLS barrier disruption at all the test sites. Therefore, quercetin topically applied after induction of irritant contact dermatitis does not appear to increase the recovery of barrier function and erythema caused by SLS.


Asunto(s)
Antiinflamatorios/uso terapéutico , Antioxidantes/uso terapéutico , Dermatitis Irritante/tratamiento farmacológico , Irritantes/efectos adversos , Quercetina/uso terapéutico , Dodecil Sulfato de Sodio/efectos adversos , Tensoactivos/efectos adversos , Administración Cutánea , Adulto , Análisis de Varianza , Antiinflamatorios/administración & dosificación , Antioxidantes/administración & dosificación , Área Bajo la Curva , Eritema/tratamiento farmacológico , Femenino , Estudios de Seguimiento , Humanos , Masculino , Vehículos Farmacéuticos , Placebos , Quercetina/administración & dosificación , Piel/efectos de los fármacos , Pérdida Insensible de Agua/efectos de los fármacos
6.
Eur J Drug Metab Pharmacokinet ; 23(2): 350-5, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9725505

RESUMEN

The effectiveness of a new beta-D-galactosidase pellet formulation in the treatment of lactose intolerance was studied. The encapsuled beta-D-galactosidase (lactase) pellets were first tested in vitro for their enzymatic activity within an environment simulating gastric conditions and subsequently within an environment simulating duodenal conditions. Effectiveness was measured by the % of glucose formed by hydrolysis of lactose. The pellets were found to retain their enzymatic activity in gastric pH conditions (mean 69 +/- 1 mg/dl glucose) and were found to hydrolyse lactose in human duodenal fluid (106.35 +/- 1 mg/dl). Finally the effectiveness of the new lactase formulation on glucose absorption was studied in 8 lactose intolerant subjects in a randomized, double blind, crossover trial. After fasting, the subjects were given one capsule containing 100 u/ml beta-galactosidase (i.e. 10 pellets of 10 u/ml each) or one capsule containing placebo pellets, followed by 100 g lactose dissolved in water. The washout period between lactose challenges was one week. Plasma glucose concentrations were measured before and at intervals after the challenges and the subjects completed symptom questionnaires every eight hours for 24 hours. Results showed a statistically significant increase in plasma glucose levels 30, 60, 90 and 120 min after lactose ingestion (repeated measures analysis of variance, p<0.01). Subjective ratings of the severity of abdominal cramping, belching, flatulence, vomiting and diarrhoea were significantly decreased following ingestion of the lactase pellets and lactose (no incidence of diarrhoea) compared with after ingestion of placebo and lactose. The results of the study were considered to be very promising as the beta-D-galactosidase formulation (which was produced at very low cost and with great ease) resisted inactivation in the stomach, effectively transformed lactose to glucose in vivo and reduced symptoms of lactose intolerance.


Asunto(s)
Intolerancia a la Lactosa/tratamiento farmacológico , beta-Galactosidasa/uso terapéutico , Adulto , Glucemia/metabolismo , Cápsulas , Humanos , Resultado del Tratamiento
7.
Cell Biol Int ; 22(9-10): 695-9, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-10452840

RESUMEN

The action of theophylline on the uptake of alpha-aminoisobutyric acid (AIB; an indicator of anti-inflammatory potency) stimulated by the glucocorticoid, dexamethasone, in cultured rat fibroblast monolayers was evaluated. Theophylline alone (0.1 m m) did not show significant activity (3314+/-27 cpm) compared with the baseline level (3186+/-130 cpm), but in the presence of 10 n m dexamethasone the stimulation of AIB uptake was increased to 5263+/-100 cpm, approximately to the same extent as with 100 n m dexamethasone alone (5397+/-28 cpm). Activation of glucocorticoid-receptor complexes in rat fibroblast cytosol was studied by assessing the extent of their binding to DNA-cellulose. Activated and non-activated forms of glucocorticoid-receptor complexes were analysed by DEAE-Sephadex chromatography. Theophylline (1 m m) was found to have a direct effect (0 degrees C), similar to that of heat (25 degrees C) on DNA-cellulose binding, that is approximately 64.5% and 68.7%, respectively, thus indicating that theophylline promotes activation of glucocorticoid receptors at low temperature. The effect of theophylline on the stimulation of AIB uptake by dexamethasone when considered in the light of its activation of GR receptors in the fibroblast cytosol indicates that this effect may be mediated by GR activation.


Asunto(s)
Ácidos Aminoisobutíricos/metabolismo , Antiinflamatorios/farmacología , Dexametasona/farmacología , Receptores de Glucocorticoides/efectos de los fármacos , Receptores de Glucocorticoides/metabolismo , Teofilina/farmacología , Animales , Antiinflamatorios/administración & dosificación , Transporte Biológico Activo/efectos de los fármacos , Células Cultivadas , Citosol/metabolismo , Dexametasona/administración & dosificación , Interacciones Farmacológicas , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Ratas , Piel/efectos de los fármacos , Piel/metabolismo , Teofilina/administración & dosificación
8.
Int J Cosmet Sci ; 17(4): 157-63, 1995 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19245484

RESUMEN

Synopsis Solar ultraviolet radiation (UVR) is implicated in many types of skin damage, such as photodermatoses, photoageing, erythema, pigmentation, skin cancer etc. Free radicals and reactive oxygen species are considered to play an important role in cutaneous photocarcinogenesis. But skin is endowed with photoprotective agents, namely melanins and antioxidant enzymatic and non-enzymatic mechanisms. In this study we describe the in vivo electron spin resonance (ESR) signals of melanins after UVR exposure, using skin specimens of various types of mice, which were taken from different parts of their bodies. The ESR signals were used as a model for testing the antioxidant properties of butylated hydroxyanisole, tocopherol acetate, and octyl p-methoxycinnamate with butyl methoxy dibenzoyl methane and superoxide dismutase (SOD). Additional UVB radiation was applied to the skin samples in situ (in the cavity of the ESR spectrometer). Suppression of ESR signals of melanins was observed in all cases. Etudes in vivo par resonance paramagnetique electronique, après exposition au rayonnement UV, des méchanismes radicalans impliqués a la photocarcinogénèse cutanée.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA